StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > The Weekend is coming...

<< Previous

Bullboard Posts

Next >>

Comment by gojotv!on Jun 18, 2021 4:14pm

194 Views

Post# 33412806

RE:RE:The Weekend is coming...

That's the trouble with a tsunami... too much good news to keep track of it all!
Think. If just a mere 10% of StayWell's patients get tested, that's 200,000 patients! And you KNOW they'll want more screened, because it's an aging population, and cancer is expensive to treat! Aristotle could save StayWell millions of dollars! They must be raring to go!
Know what happens when you back a company that's doing so much good?...

LithLover wrote: Don't forget:

-partnering with Shift Communications our new media partner,
-the interview with Investorintel and Dr Meakin
-Tripp mentioning the OTCQB listing in his interview

gojotv! wrote: ...and everyone will have had time by Monday to digest the tsunami of revelations we've seen this week...

Password-protected sign-in pages for major employers and healthcare concerns on the StageZero website... (hmmm... clients like StayWell in Florida are realizing the cost benefit of early cancer detection for their two (2) Million users...!)

Care Oncology first dibs on Aristotle taken up. Now being aggressively marketed to the wider market (Q2 financials should be very interesting...!)

Covid testing now made readily available in time for the anticipated summer/fall travel boom. (should double, or even triple+ our already healthy Covid testing revenues)

Hiring at StageZero labs steady, nearly doubled staff in the last six months. (nudge, nudge, wink wink)

Bashers and trolls caught lying with every post, and sounding more desperate than ever. (always a great sign, lol!)

It's becoming pretty clear that Tripp's strategy is to under-promise and over-deliver. Smart when we see so many glib CEO's end up not delivering the goods. We'll see who can still get in at these prices, but when folks have had a little sit and think, we'll see who's an investor, and who's allergic to money, lol.
GLTA!